HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events | Zendy

Anand Rohatgi | Zendy; Amit Khera | Zendy; Jarett D. Berry | Zendy; Edward G. Givens | Zendy; Colby Ayers | Zendy; Kyle E. Wedin | Zendy; Ian J. Neeland | Zendy; Ivan S. Yuhanna | Zendy; Daniel Rader | Zendy; James A. de Lemos | Zendy; Philip W. Shaul | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

Author(s) -

Anand Rohatgi,

Amit Khera,

Jarett D. Berry,

Edward G. Givens,

Colby Ayers,

Kyle E. Wedin,

Ian J. Neeland,

Ivan S. Yuhanna,

Daniel Rader,

James A. de Lemos,

Philip W. Shaul

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1409065

Subject(s) - medicine , cholesterol , efflux , reverse cholesterol transport , risk factor , high density lipoprotein , population , cohort , lipoprotein , endocrinology , environmental health , biology , biochemistry

It is unclear whether high-density lipoprotein (HDL) cholesterol concentration plays a causal role in atherosclerosis. A more important factor may be HDL cholesterol efflux capacity, the ability of HDL to accept cholesterol from macrophages, which is a key step in reverse cholesterol transport. We investigated the epidemiology of cholesterol efflux capacity and its association with incident atherosclerotic cardiovascular disease outcomes in a large, multiethnic population cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research